Levophenacylmorphan
![]() | |
| Systematic (IUPAC) name | |
|---|---|
|
(−)-3-Hydroxy-N-phenacylmorphinan | |
| Clinical data | |
| Legal status | |
| Legal status |
|
| Identifiers | |
| CAS Number |
10061-32-2 |
| ATC code | none |
| PubChem | CID 5362482 |
| ChemSpider |
16736786 |
| UNII |
7Q24AL2BR2 |
| Synonyms | Levophenacylmorphan |
| Chemical data | |
| Formula | C24H27NO2 |
| Molar mass | 361.48 g/mol |
| |
| |
| | |
Levophenacylmorphan is a morphinan derivative that acts as an opioid agonist. It has potent analgesic effects and is around 10x more potent than morphine.[1] Adverse effects associated with its use are those of the opioids as a whole, including pruritus, nausea, respiratory depression, euphoria and development of tolerance and dependence to its effects.[2]
See also
References
- ↑ MAY, E.L. & EDDY, N.B., A New Potent Synthetic Analgesic, J. Org. Chem., 24 : 294, 1959.
- ↑ Fraser HF, Isbell H. Human pharmacology and addiction liabilities of phenazocine and levophenacylmorphan. UN Bulletin on Narcotics. 1960 Issue 2
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
